News

FDA is to hold public meeting to discuss reasons for drug shortages

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d5650 (Published 05 September 2011) Cite this as: BMJ 2011;343:d5650
  1. Bob Roehr
  1. 1Washington, DC

The US Food and Drug Administration will hold a public workshop on 26 September to discuss why the United States is experiencing shortages of certain drugs, especially those for treating cancer, and to discuss solutions.

Anecdotal accounts suggest that the shortages have led to delayed treatment of some patients or the use of secondary options to treat serious diseases such as cancer.

The problem is not new. An average of 114 drugs a year have been in short supply over the past decade, ranging from 58 in 2004 to 211 in 2010. Shortages have been reported for 180 drugs from mid-summer this year, reports the University of Utah’s drug information …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe